IMMUNIC, INC. Research And Development Expense

Quick Answer

IMMUNIC, INC. reported Research And Development Expense of $81.98 million for the year ending 2025.

  • IMMUNIC, INC. showed an increase of +2.4% in Research And Development Expense from 2024 to 2025.
  • This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $3.43 million | Q2 2013: $4.54 million | Q3 2013: $6.16 million | Q1 2014: $9.22 million | Q2 2014: $9.13 million | Q3 2014: $10.24 million | Q1 2015: $11.75 million | Q2 2015: $11.55 million | Q3 2015: $9.65 million | Q1 2016: $6.86 million | Q2 2016: $6.86 million | Q3 2016: $7.47 million | Q1 2017: $9.63 million | Q2 2017: $9.83 million | Q3 2017: $9.69 million | Q1 2018: $10.16 million | Q2 2018: $2.16 million | Q3 2018: $1.41 million | Q1 2019: $3.36 million | Q2 2019: $6.03 million | Q3 2019: $7.10 million | Q1 2020: $6.43 million | Q2 2020: $9.99 million | Q3 2020: $11.04 million | Q1 2021: $11.52 million | Q2 2021: $15.74 million | Q3 2021: $15.48 million | Q1 2022: $17.45 million | Q2 2022: $16.54 million | Q3 2022: $16.54 million | Q1 2023: $22.96 million | Q2 2023: $21.17 million | Q3 2023: $19.80 million | Q1 2024: $18.74 million | Q2 2024: $18.32 million | Q3 2024: $21.37 million | Q1 2025: $21.53 million | Q2 2025: $21.37 million | Q3 2025: $20.01 million.
  • Over the full 14 years of available data (2012 to 2025), IMMUNIC, INC.'s Research And Development Expense has grown by 1,508.5%.
  • Historical annual values: Fiscal year 2025: $81.98 million | Fiscal year 2024: $80.05 million | Fiscal year 2023: $83.22 million | Fiscal year 2022: $71.26 million | Fiscal year 2021: $61.12 million | Fiscal year 2020: $38.64 million | Fiscal year 2019: $22.51 million | Fiscal year 2018: $9.60 million | Fiscal year 2017: $39.34 million | Fiscal year 2016: $30.05 million | Fiscal year 2015: $39.77 million | Fiscal year 2014: $39.48 million | Fiscal year 2013: $21.79 million | Fiscal year 2012: $5.10 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: